VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AMRZ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AMRZAmrize Ltd
$41.87$23.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMRZBalance Sheet

Amrize Ltd (AMRZ) Balance Sheet

4Y historyFree accessUpdated daily

Debt-to-equity improved to 0.51 in 2026Q3 as total debt fell to $6.5B, but cash of only $299M against that debt leaves a net debt position of roughly $6.2B that must be serviced from seasonally uneven cash flow.

Income StatementBalance SheetCash FlowRatios

AMRZ Balance Sheet

Annual statement

AMRZ Balance Sheet

Amrize Ltd (AMRZ) balance sheet — 4-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22
Total Current Assets4.23B4.68B4.49B3.94B3.16B
Cash & Short-Term Investments299M1.92B1.82B1.11B351M
Cash Only299M1.92B1.82B1.11B351M
Short-Term Investments00000
Accounts Receivable2.17B1.12B1.07B1.4B1.41B
Days Sales Outstanding49.7834.633.3443.747.98
Inventory1.57B1.55B1.45B1.31B1.23B
Days Inventory Outstanding61.6264.4761.3853.5554.3
Other Current Assets198M88M144M40M51M
Total Non-Current Assets20.13B19.57B19.03B19.11B17.51B
Property, Plant & Equipment9.16B8.54B8.08B8.07B7.75B
Fixed Asset Turnover1.38x1.38x1.45x1.45x1.38x
Goodwill9.06B9.02B8.92B8.97B8.12B
Intangible Assets1.66B1.73B1.83B1.88B1.44B
Long-Term Investments0056M63M0
Other Non-Current Assets251M277M198M121M202M
Total Assets24.36B24.25B23.52B23.05B20.67B
Asset Turnover0.50x0.49x0.50x0.51x0.52x
Asset Growth %16.7%3.11%2.04%11.5%-
Total Current Liabilities3.96B2.86B2.43B2.44B2.25B
Accounts Payable1.27B1.54B1.37B1.25B1.14B
Days Payables Outstanding51.1763.9358.0951.1450.59
Short-Term Debt1.74B333M5M131M348M
Deferred Revenue (Current)00048M43M
Other Current Liabilities946M850M902M532M464M
Current Ratio1.07x1.64x1.85x1.61x1.40x
Quick Ratio0.67x1.10x1.25x1.08x0.86x
Cash Conversion Cycle60.2335.1436.6446.1251.7
Total Non-Current Liabilities7.63B8.14B7.78B11.4B10.21B
Long-Term Debt4.24B4.94B4.94B8.64B7.62B
Capital Lease Obligations2.01B500M698M564M516M
Deferred Tax Liabilities3.36B0937M998M944M
Other Non-Current Liabilities1.76B2.7B868M930M873M
Total Liabilities11.6B10.99B10.21B13.84B12.46B
Total Debt6.5B5.91B5.79B9.52B8.66B
Net Debt6.21B3.98B3.96B8.42B8.31B
Debt / Equity0.51x0.45x0.43x1.03x1.05x
Debt / EBITDA2.25x2.09x1.93x3.48x3.48x
Net Debt / EBITDA2.14x1.41x1.32x3.07x3.34x
Interest Coverage5.71x4.62x7.09x3.37x6.89x
Total Equity12.76B13.25B13.31B9.2B8.21B
Equity Growth %6.92%-0.4%44.59%12.1%-
Book Value per Share23.3923.9424.0516.6514.85
Total Shareholders' Equity12.76B13.25B13.31B9.2B8.21B
Common Stock013.25B6M00
Retained Earnings00000
Treasury Stock00000
Accumulated OCI00-604M-317M-372M
Minority Interest00-1M01M

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Seasonal leverage and cash volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Deleveraging Balance Sheet Stabilizing Post-Separation

Based on EDBL's reported figures, AMRZ's debt-to-equity ratio moved from 1.04 in 2024Q3 to 0.51 in 2026Q3, as total debt fell from $10.2B to $6.5B while equity rebuilt to $12.8B after the separation.

The sharp drop in leverage from the 2024Q3 peak suggests the separation reset the capital structure rather than reflecting organic debt paydown alone. The reported figures show a fairly stable 0.45 to 0.53 band across the last eight quarters, which implies the balance sheet has settled into a steady state. Investors should monitor whether this stability holds once standalone capital allocation policies are fully established.

Leverage Moderate Despite Heavy Gross Borrowings

As reported in the quarterly statements, AMRZ carried $6.5B of total debt in 2026Q3 against $299M of cash, a net debt position of roughly $6.2B that the company must service from seasonally uneven operating cash flow.

Gross debt of this scale relative to a 0.51 debt-to-equity ratio indicates the company relies on its equity base to support a substantial borrowing load. The gap between gross debt and cash in the most recent quarter suggests limited near-term liquidity buffer outside the winter-to-spring working capital cycle. Refinancing schedules and maturity profiles are not disclosed in the supplied data and warrant further investigation.

Current Ratio Thins From Year-End Peak

Based on the supplied quarterly data, AMRZ's current ratio declined from 1.85 in 2024Q4 to 1.07 in 2026Q3, with cash falling from $1.9B at 2025Q4 to $299M, indicating a meaningful drawdown of liquid reserves.

The compression in the current ratio and cash balance over the last three quarters appears to reflect capital deployment, including reported buybacks and acquisition outflows, alongside seasonal working capital build. A current ratio near 1.0 leaves limited cushion against an unexpected shock to receivables or inventory. The trend warrants close monitoring given the business's dependence on seasonal cash generation.

Heavy Fixed Asset Base Anchors Balance Sheet

According to recent SEC filings, AMRZ's net PPE of $9.2B represents roughly 38% of total assets of $24.4B in 2026Q3, with goodwill of $9.1B contributing a similar share, together indicating a capital-intensive and acquisition-shaped asset profile.

The near-equal split between PPE and goodwill suggests the asset base reflects both heavy cement and aggregates infrastructure and a legacy of acquisitions in roofing and building products. Goodwill at this scale implies meaningful impairment exposure if segment returns weaken, particularly within the Solutions and Products business. The steady PPE trajectory from $8.1B to $9.2B across the period indicates ongoing reinvestment rather than asset run-off.

Headline Equity Masks Goodwill Dependence

Based on reported figures, AMRZ's equity of $12.8B would fall materially below its $9.1B goodwill plus PPE if intangible-heavy assets were excluded, suggesting tangible book value may be considerably thinner than headline equity implies.

Retained earnings showing as zero across most periods limits the ability to assess how much of equity reflects accumulated profitability versus separation-related capital allocation. The strong equity figure may therefore rest substantially on carve-out accounting rather than organic earnings retention. This distortion warrants further investigation before treating the low leverage ratio as fully representative of underlying balance sheet strength.

AMRZ — Frequently Asked Questions

Quick answers to the most common questions about buying AMRZ stock.

What are the total assets of Amrize Ltd (AMRZ)?

As of 2025, Amrize Ltd (AMRZ) had total assets of $24.25B including $4.68B in current assets.

How much debt does Amrize Ltd (AMRZ) have?

Amrize Ltd (AMRZ) carries total debt of $5.91B, offset by $1.92B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Amrize Ltd?

Amrize Ltd (AMRZ) has total shareholders' equity (book value) of $13.25B ($23.94 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Amrize Ltd's current ratio and liquidity?

Amrize Ltd (AMRZ) reported a current ratio of 1.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.